The ProtekDuo Cannula: A Comprehensive Review of Efficacy and Clinical Applications in Right Ventricular Failure

• Published in: Journal of clinical medicine Vol. 13; no. 14; p. 4077
• Main Authors: Brewer, Joseph M, Maybauer, Marc O
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 12.07.2024
• Subjects: Cohort analysis; Etiology; Extracorporeal membrane oxygenation; Hemodynamics; Weaning; mechanical circulatory support; RVAD; right ventricular failure; right ventricular assist device; ProtekDuo
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm13144077

Right ventricular failure (RVF) is a clinical challenge associated with various underlying acute and chronic medical conditions, necessitating diverse management strategies including mechanical circulatory support (MCS). The ProtekDuo cannula represents an important advancement in medical devices for MCS in the setting of RVF. When combined with an extracorporeal blood pump, the dual-lumen design allows for direct bypass of the RV using simultaneous drainage and return of blood using percutaneous, single-site access. Studies have reported favorable outcomes with the ProtekDuo cannula and low device-related complications, but comparative studies with other MCS devices are limited. Still, the ProtekDuo cannula has numerous advantages; however, it is not without challenges, and opportunities for further research exist. The ProtekDuo cannula holds significant potential for future advancements in the field of MCS, offering promising solutions for RVF management.